PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
10-Jan-2020 AEVIS VICTORIA SA: Swiss Medical Network enters in the capital of Hôpital du Jura bernois AEVIS VICTORIA SA
10-Jan-2020 Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock Mirati Therapeutics, Inc.
09-Jan-2020 AbbVie Inc. - Form 8.1 - Statement of Stock Purchase by Director AbbVie
09-Jan-2020 Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 Million Portola Pharmaceuticals, Inc.®
09-Jan-2020 Impel NeuroPharma Announces Appointment Of Adrian Adams As Chairman Of The Board Of Directors Impel NeuroPharma
09-Jan-2020 Amgen To Present At The 38th Annual J.P. Morgan Healthcare Conference Amgen
09-Jan-2020 Blueprint Medicines Announces FDA Approval of AYVAKIT(TM) (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor Blueprint Medicines Corporation
09-Jan-2020 FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors U.S. Food and Drug Administration
09-Jan-2020 New Analysis Finds Nearly 50% of Brand Medicine Spending Goes to the Supply Chain and Others Pharmaceutical Research and Manufacturers of America (PhRMA)
09-Jan-2020 Another 160 Pharmacies Adopt Digital Pharmacist's 2-Way Messaging Product Digital Pharmacist Inc.
09-Jan-2020 Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases Almirall
09-Jan-2020 Almirall enters into an option agreement to acquire Bioniz Therapeutics and to establish a broad research agreement to further expand its innovative pipeline in medical dermatology Almirall
09-Jan-2020 The American Heart Association ("AHA") Recognizes Mezzion's FUEL Trial as the Biggest Victory in Congenital Heart Disease ("CHD") Advancements for 2019 Mezzion Pharma Co. Ltd.
09-Jan-2020 The American Heart Association ("AHA") Recognizes Mezzion's FUEL Trial as the Biggest Victory in Congenital Heart Disease ("CHD") Advancements for 2019 Mezzion Pharma Co. Ltd.
09-Jan-2020 Global Biotech Leader CSL to Present at 38th Annual J.P. Morgan Healthcare Conference CSL Behring
09-Jan-2020 Calliditas Submits Draft Registration Statement for the Listing of ADSs in the U.S. Calliditas Therapeutics
09-Jan-2020 FDA, USDA and EPA announce joint platform to streamline information about agricultural biotechnology products U.S. Food and Drug Administration
09-Jan-2020 Grey Wolf Therapeutics completes £2.5 million Series A2 financing to accelerate development of therapies targeting ERAP2 Grey Wolf Therapeutics
09-Jan-2020 Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestatâ„¢ technology Hikma Pharmaceuticals PLC
09-Jan-2020 ADC Therapeutics Announces Positive Results from Pivotal Phase 2 Clinical Trial of Single Agent Loncastuximab Tesirine (ADCT-402) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma ADC Therapeutics SA